Company Presentation Final June 2008
•
0 likes•199 views
Speid & Associates provides consultancy services to help speed new drugs to market. They have a team of expert consultants with experience in regulatory affairs, clinical development, drug development, and other areas. Their services include strategic planning, preparing regulatory submissions, conducting due diligence, assisting with clinical trials, and training company staff. They work with clients around the world to help achieve successful global drug registration.
Report
Share
Report
Share
![Staff at Speid & Associates ,[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Harmonization and Opportunites (Nov 2015)
An Outline on importance of Harmonization to deliver safe, efficacious and quality drugs to every body of globe
Biotechnology Consulting
Biotechnology consulting refers to the practice of organization involved in Pacificlinkconsulting services contact: San Diego, CA 92127 Phone: 858-335-1300
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...Obaid Ali / Roohi B. Obaid
This presentation discusses the cultural relationship between drug quality and prevailing regulatory environments. It notes that drug quality has evolved from a moral obligation to real challenges, and asks whether the quality of drugs consumed by Pakistani citizens meets minimum global standards. The presentation expresses sincere concern over the quality of drugs used by citizens and asks why quality drugs are not available for Pakistanis. It questions how and who made the Drug Regulatory Authority of Pakistan incompetent, and suggests that if DRAP became competent, drug quality would improve. The presentation concludes by emphasizing the need to make decisions to protect one's loved ones and not allow lives to be put at risk by drugs that do not meet minimum quality standards.Pistoia Alliance Debates: IDMP: It’s all about the patient: enhancing patient...
This webinar discusses IDMP (Identification of Medicinal Products) and focuses on substances and their implementation. It provides background on IDMP, timelines for implementation in the EU which is driving standardization, and an example substance record for Brentuximab Vedotin to illustrate the level of detail in substance definitions. The goal of IDMP is to improve patient safety through standardized identification and exchange of information on medicines and ingredients.
PPD Competitive Analysis
PPDI is one of the top 10 clinical research organizations that provides drug development services. It has over 6,600 employees operating in 38 locations worldwide. PPDI generates most of its revenue from late-stage clinical trials. While it has strengths like operating efficiencies, it also faces weaknesses such as lack of diversification and high employee turnover. Opportunities include expanding into new areas like medical devices and proprietary drug development, while threats include increased competition and changes in the pharmaceutical industry.
Advanced Medical Isotope Corp.- Investor Presentation
Advanced Medical Isotope Corporation is developing RadioGel, a brachytherapy device, to treat cancers in humans and animals. The company plans to generate near-term revenue from veterinary clinics and international licensing. It is working towards FDA approval for human cancer indications like skin cancer. RadioGel consists of radioactive yttrium-90 phosphate particles delivered via a hydrogel vehicle that solidifies in the body. The company expects to begin sales to veterinary clinics in early 2018 and obtain international licensing revenue. It is led by an experienced management team and advises by world-class medical and scientific boards.
CRO Industry in Japan 2008
The document discusses the contract research organization (CRO) industry in Japan in 2008. It outlines that several large international CROs have established operations in Japan, but there remains resistance from personnel, investigators, pharmaceutical manufacturers, and the government. However, factors like an aging population, need for cost-effective healthcare, and market deregulation are driving changes that will create future opportunities for CROs to grow in Japan. The CRO market in Japan was worth approximately $9.6 billion in 2007.
Pharmaceutical Consulting Firm
What we do: Pharmaceutical Consulting, Strategic Consulting, Pharmaceutical Strategic Consulting
Strategic Opportunity Assessment – Diagnostic process for continuously improving project managements performances.
Clinical site; KOL Evaluation in Asia – Development of clinical sites and evaluation of KOL treatment algorithms
Compliant manufacturing Site Proposal – Forecasting optimal asset allocation to achieve compliant manufacturing.
Recommended
Harmonization and Opportunites (Nov 2015)
An Outline on importance of Harmonization to deliver safe, efficacious and quality drugs to every body of globe
Biotechnology Consulting
Biotechnology consulting refers to the practice of organization involved in Pacificlinkconsulting services contact: San Diego, CA 92127 Phone: 858-335-1300
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...Obaid Ali / Roohi B. Obaid
This presentation discusses the cultural relationship between drug quality and prevailing regulatory environments. It notes that drug quality has evolved from a moral obligation to real challenges, and asks whether the quality of drugs consumed by Pakistani citizens meets minimum global standards. The presentation expresses sincere concern over the quality of drugs used by citizens and asks why quality drugs are not available for Pakistanis. It questions how and who made the Drug Regulatory Authority of Pakistan incompetent, and suggests that if DRAP became competent, drug quality would improve. The presentation concludes by emphasizing the need to make decisions to protect one's loved ones and not allow lives to be put at risk by drugs that do not meet minimum quality standards.Pistoia Alliance Debates: IDMP: It’s all about the patient: enhancing patient...
This webinar discusses IDMP (Identification of Medicinal Products) and focuses on substances and their implementation. It provides background on IDMP, timelines for implementation in the EU which is driving standardization, and an example substance record for Brentuximab Vedotin to illustrate the level of detail in substance definitions. The goal of IDMP is to improve patient safety through standardized identification and exchange of information on medicines and ingredients.
PPD Competitive Analysis
PPDI is one of the top 10 clinical research organizations that provides drug development services. It has over 6,600 employees operating in 38 locations worldwide. PPDI generates most of its revenue from late-stage clinical trials. While it has strengths like operating efficiencies, it also faces weaknesses such as lack of diversification and high employee turnover. Opportunities include expanding into new areas like medical devices and proprietary drug development, while threats include increased competition and changes in the pharmaceutical industry.
Advanced Medical Isotope Corp.- Investor Presentation
Advanced Medical Isotope Corporation is developing RadioGel, a brachytherapy device, to treat cancers in humans and animals. The company plans to generate near-term revenue from veterinary clinics and international licensing. It is working towards FDA approval for human cancer indications like skin cancer. RadioGel consists of radioactive yttrium-90 phosphate particles delivered via a hydrogel vehicle that solidifies in the body. The company expects to begin sales to veterinary clinics in early 2018 and obtain international licensing revenue. It is led by an experienced management team and advises by world-class medical and scientific boards.
CRO Industry in Japan 2008
The document discusses the contract research organization (CRO) industry in Japan in 2008. It outlines that several large international CROs have established operations in Japan, but there remains resistance from personnel, investigators, pharmaceutical manufacturers, and the government. However, factors like an aging population, need for cost-effective healthcare, and market deregulation are driving changes that will create future opportunities for CROs to grow in Japan. The CRO market in Japan was worth approximately $9.6 billion in 2007.
Pharmaceutical Consulting Firm
What we do: Pharmaceutical Consulting, Strategic Consulting, Pharmaceutical Strategic Consulting
Strategic Opportunity Assessment – Diagnostic process for continuously improving project managements performances.
Clinical site; KOL Evaluation in Asia – Development of clinical sites and evaluation of KOL treatment algorithms
Compliant manufacturing Site Proposal – Forecasting optimal asset allocation to achieve compliant manufacturing.
Clinical Pharmacology Expert
CTC Resourcing Solutions is a specialist staffing organization based in Basel, London, and Munich providing flexible staffing to the pharmaceutical industry. They are currently looking for a Clinical Pharmacology Expert based in Basel, Switzerland to support oncology drug development. The position responsibilities include providing pharmacokinetic expertise, designing clinical pharmacology strategies, analyzing and reporting data, and ensuring collaboration within drug development teams. Qualifications include a Ph.D. in pharmacokinetics or related field with 6-10 years experience, expertise in related disciplines, experience using analysis tools, and strong communication and project management skills.
20160208procelsis_presentation_v1_4
Procelsis provides strategic consulting services to pharmaceutical, biotech, medical device, and CRO companies. Services include strategic support for M&A deals, clinical development plans, outsourcing and offshoring, and interim management. Dr. Antal Hajos, with over 25 years of experience in pharma and CROs, founded Procelsis and serves as a consultant, advisor, and interim executive focusing on performance improvement and strategic initiatives.
Outsourcing in pharma
This document discusses outsourcing in the pharmaceutical industry. It defines outsourcing as transferring portions of work to outside suppliers in order to reduce costs. The main types of outsourcing in pharma include research and development, clinical trials, manufacturing, packaging, and sales/marketing. The key drivers of outsourcing are focusing on core strengths, reducing costs, and decreasing time to market. While outsourcing provides advantages like cost reductions, it also presents risks such as loss of managerial control and internal talent. Overall, outsourcing allows pharma companies to exploit new drug technologies while solving problems, though successful management of vendor relationships is critical.
New Product Planning and Medical Affairs
A workshop presentation for Medical Affairs Strategic Summit West held in San Diego on September 23, 2019. The workshop covered the following learning objectives:
* Understand the factors involved in selecting and prioritizing indications
* Understand the importance of strategic market segmentation
* Understand how Medical Affairs can be involved in the process of new product planning
Webinar slides: ISO IDMP via Regulatory Master Data Management
The presentation complemented a 60 minutes webinar on ISO IDMP provided by Cunesoft in May 2015. Benefits of a regulatory master data management system are being analyzed. The entire webinar was recorded. The latest information on IDMP can be accessed on our website: https://www.phlexglobal.com/idmp
J & J Solutions Executive Summary 1 Page
J & J Solutions has developed a closed system transfer device for safer handling of chemotherapy drugs. Their device eliminates risks of contamination, standardizes compounding to reduce errors, improves workflow efficiency, and reduces costs. They are seeking funding to complete product development including alpha and beta testing, obtain FDA approval, and launch the product to address a $1 billion market that is growing due to increasing cancer rates.
Resume Paul Rohricht MS, MBA
This document provides a summary of Paul Rohricht's professional experience and qualifications. It outlines his experience in business development, strategic planning, transaction structuring, and executive management roles in the biotechnology industry, with over $450 million in transactions completed. It details positions held at various biotech companies, including founding several startups, and highlights accomplishments such as negotiating licensing deals, securing funding, and growing revenues.
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Due Diligence - New Strategies for Successful Licensing Acquisitions , DIA , Session Panel, June 22 2008,
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...Obaid Ali / Roohi B. Obaid
1) The document discusses the cultural relationship between the quality of drugs and the prevailing regulatory environment in Pakistan. It notes that while over 500 pharmaceutical manufacturing facilities are located in Pakistan, the quality of drugs has yet to meet modern world standards.
2) It emphasizes that to compete globally, Pakistani drug manufacturers must apply harmonized quality standards such as those outlined in ICH guidelines and obtain membership in organizations like PIC/S. Demonstrating consistent quality and safety of generic drugs through rigorous testing and inspections is important.
3) Developing a "culture of quality" through collaborative efforts between industry, regulators and government, with transparent communication, is key to improving drug standards and reducing the gap with international levels of qualityVentac Partners China Business
Fundraising and strategic partnering services for healthcare companies who are looking for China based partners and venture capital investors.
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
This document discusses Pakistan's pharmaceutical regulatory practices and scientific issues. It identifies several areas for improvement, including organizational competency and pre/post-market reviews. It recommends simplifying regulations, conducting third-party inspections, and adopting emerging regulatory sciences to strengthen the system and keep the "wheel of change moving". The overall goal is to develop a regulatory framework that is science-based, risk-focused, and aligned with global standards.
How does the licensing process differ for in-licensing and out-licensing comp...
PHARMA & BIOTECH LICENSING & PARTNERING:
Filling the Pipeline & Growing Market Share Through Strategic Deal-Making-- March 2-3- San Diego California
Medelis Overview - A Specialized Oncology CRO - Q315
Medelis is a specialty CRO that focuses on oncology clinical trials from Phase I to Phase III. It prides itself on building strong client relationships and delivering oncology expertise at every stage of a clinical trial, from protocol development to site management and medical writing. Medelis employs highly experienced operational staff with extensive experience managing oncology studies, and provides dedicated and flexible project management for each client's trial. Its goal is ensuring clients' success through innovative solutions and cost certainty throughout their studies.
Pharmaceutical competitive intelligence
Competitive intelligence in the pharmaceutical industry involves systematically collecting and analyzing information about competitors' objectives, strategies, capabilities, and assumptions. It benefits pharmaceutical companies by incorporating external market forces into strategic planning, enhancing various business functions, and minimizing decision risk. Competitive intelligence for pharma focuses on monitoring competitors' product development, pricing strategies, and commercial priorities throughout a product's lifecycle from research to marketing. It is important for pharmaceutical companies to establish strategic competitive intelligence functions that reach across departments to gather and share critical competitor information.
3716_A5_Capabilities_Brochure_R7
TranScrip provides services across the pharmaceutical development lifecycle including translational medicine, clinical development, regulatory affairs, medical affairs, drug safety, and portfolio management. They help biotech and pharmaceutical clients address challenges and achieve their drug development and commercialization goals. Their teams integrate seamlessly with clients and provide expertise, oversight, and flexible support to maximize opportunities and reduce risks throughout the drug development process from early research through commercialization.
Clinical sas course syllabus
The document outlines the syllabus for a Clinical SAS course focusing on drug discovery and development processes. The syllabus covers an introduction to clinical trials including their phases and regulations, preparing and analyzing clinical trial data using SAS, generating tables, listings and graphs from clinical data, and performing statistical analyses. Students will learn how to clean, categorize and summarize clinical data, create analysis datasets, report adverse events, and obtain descriptive and inferential statistics to analyze efficacy, safety and time-to-event data. The course aims to provide skills relevant for clinical data management roles in the pharmaceutical industry.
resumeHirokoOtao_20161023
Hiroko Otao has over 10 years of experience in project management and clinical research. She has managed over 40 clinical studies for conditions such as psoriasis, asthma, and COPD while working at CMIC CRO and GlaxoSmithKline. Her experience includes vendor management, budgeting, reporting, customs clearance, and translating documents between English and Japanese. She is proficient in English, Mac and PC programs, and has a B.A. in Agricultural Science from Tokyo University of Agriculture.
Market Access Climate Change Webinar_the Evolving Impact of Product Listing A...
The document discusses recent developments regarding product listing agreements (PLAs) with the pan-Canadian Pharmaceutical Alliance (pCPA) and private payers in Canada. It notes that the pCPA office is now operational, which could standardize and improve the negotiation process. It also discusses Quebec recently joining pCPA negotiations, which may lead to more products being listed faster in that province. The document also examines the growing interest of private payers in Canada in negotiating their own PLAs, especially for specialty products, and finds that these agreements will likely become more important and prevalent over time.
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy post-approval solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Presentation for UMass Workshop
How True Open Innovation TM and its global network can expand the opportunity for drug development by increasing efficiency and decreasing costs
Luca Rastelli, PhD
Boston Strategics Corporation
October, 2013
Regulatory Affairs 2010
Speid and Associates is a Regulatory Affairs and Drug Development Consultancy Company. (Slides produced in 2010)
INC Research Consulting v1
INC Research is a global consulting firm that provides advisory and implementation support services to the biopharmaceutical industry. They help clients with development, regulatory, quality and compliance, pharmacovigilance, and market development. Their team of over 50 consultants uses therapeutic expertise and consulting frameworks to deliver strategic solutions and help clients achieve their business goals.
More Related Content
What's hot
Clinical Pharmacology Expert
CTC Resourcing Solutions is a specialist staffing organization based in Basel, London, and Munich providing flexible staffing to the pharmaceutical industry. They are currently looking for a Clinical Pharmacology Expert based in Basel, Switzerland to support oncology drug development. The position responsibilities include providing pharmacokinetic expertise, designing clinical pharmacology strategies, analyzing and reporting data, and ensuring collaboration within drug development teams. Qualifications include a Ph.D. in pharmacokinetics or related field with 6-10 years experience, expertise in related disciplines, experience using analysis tools, and strong communication and project management skills.
20160208procelsis_presentation_v1_4
Procelsis provides strategic consulting services to pharmaceutical, biotech, medical device, and CRO companies. Services include strategic support for M&A deals, clinical development plans, outsourcing and offshoring, and interim management. Dr. Antal Hajos, with over 25 years of experience in pharma and CROs, founded Procelsis and serves as a consultant, advisor, and interim executive focusing on performance improvement and strategic initiatives.
Outsourcing in pharma
This document discusses outsourcing in the pharmaceutical industry. It defines outsourcing as transferring portions of work to outside suppliers in order to reduce costs. The main types of outsourcing in pharma include research and development, clinical trials, manufacturing, packaging, and sales/marketing. The key drivers of outsourcing are focusing on core strengths, reducing costs, and decreasing time to market. While outsourcing provides advantages like cost reductions, it also presents risks such as loss of managerial control and internal talent. Overall, outsourcing allows pharma companies to exploit new drug technologies while solving problems, though successful management of vendor relationships is critical.
New Product Planning and Medical Affairs
A workshop presentation for Medical Affairs Strategic Summit West held in San Diego on September 23, 2019. The workshop covered the following learning objectives:
* Understand the factors involved in selecting and prioritizing indications
* Understand the importance of strategic market segmentation
* Understand how Medical Affairs can be involved in the process of new product planning
Webinar slides: ISO IDMP via Regulatory Master Data Management
The presentation complemented a 60 minutes webinar on ISO IDMP provided by Cunesoft in May 2015. Benefits of a regulatory master data management system are being analyzed. The entire webinar was recorded. The latest information on IDMP can be accessed on our website: https://www.phlexglobal.com/idmp
J & J Solutions Executive Summary 1 Page
J & J Solutions has developed a closed system transfer device for safer handling of chemotherapy drugs. Their device eliminates risks of contamination, standardizes compounding to reduce errors, improves workflow efficiency, and reduces costs. They are seeking funding to complete product development including alpha and beta testing, obtain FDA approval, and launch the product to address a $1 billion market that is growing due to increasing cancer rates.
Resume Paul Rohricht MS, MBA
This document provides a summary of Paul Rohricht's professional experience and qualifications. It outlines his experience in business development, strategic planning, transaction structuring, and executive management roles in the biotechnology industry, with over $450 million in transactions completed. It details positions held at various biotech companies, including founding several startups, and highlights accomplishments such as negotiating licensing deals, securing funding, and growing revenues.
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Due Diligence - New Strategies for Successful Licensing Acquisitions , DIA , Session Panel, June 22 2008,
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...Obaid Ali / Roohi B. Obaid
1) The document discusses the cultural relationship between the quality of drugs and the prevailing regulatory environment in Pakistan. It notes that while over 500 pharmaceutical manufacturing facilities are located in Pakistan, the quality of drugs has yet to meet modern world standards.
2) It emphasizes that to compete globally, Pakistani drug manufacturers must apply harmonized quality standards such as those outlined in ICH guidelines and obtain membership in organizations like PIC/S. Demonstrating consistent quality and safety of generic drugs through rigorous testing and inspections is important.
3) Developing a "culture of quality" through collaborative efforts between industry, regulators and government, with transparent communication, is key to improving drug standards and reducing the gap with international levels of qualityVentac Partners China Business
Fundraising and strategic partnering services for healthcare companies who are looking for China based partners and venture capital investors.
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
This document discusses Pakistan's pharmaceutical regulatory practices and scientific issues. It identifies several areas for improvement, including organizational competency and pre/post-market reviews. It recommends simplifying regulations, conducting third-party inspections, and adopting emerging regulatory sciences to strengthen the system and keep the "wheel of change moving". The overall goal is to develop a regulatory framework that is science-based, risk-focused, and aligned with global standards.
How does the licensing process differ for in-licensing and out-licensing comp...
PHARMA & BIOTECH LICENSING & PARTNERING:
Filling the Pipeline & Growing Market Share Through Strategic Deal-Making-- March 2-3- San Diego California
Medelis Overview - A Specialized Oncology CRO - Q315
Medelis is a specialty CRO that focuses on oncology clinical trials from Phase I to Phase III. It prides itself on building strong client relationships and delivering oncology expertise at every stage of a clinical trial, from protocol development to site management and medical writing. Medelis employs highly experienced operational staff with extensive experience managing oncology studies, and provides dedicated and flexible project management for each client's trial. Its goal is ensuring clients' success through innovative solutions and cost certainty throughout their studies.
Pharmaceutical competitive intelligence
Competitive intelligence in the pharmaceutical industry involves systematically collecting and analyzing information about competitors' objectives, strategies, capabilities, and assumptions. It benefits pharmaceutical companies by incorporating external market forces into strategic planning, enhancing various business functions, and minimizing decision risk. Competitive intelligence for pharma focuses on monitoring competitors' product development, pricing strategies, and commercial priorities throughout a product's lifecycle from research to marketing. It is important for pharmaceutical companies to establish strategic competitive intelligence functions that reach across departments to gather and share critical competitor information.
3716_A5_Capabilities_Brochure_R7
TranScrip provides services across the pharmaceutical development lifecycle including translational medicine, clinical development, regulatory affairs, medical affairs, drug safety, and portfolio management. They help biotech and pharmaceutical clients address challenges and achieve their drug development and commercialization goals. Their teams integrate seamlessly with clients and provide expertise, oversight, and flexible support to maximize opportunities and reduce risks throughout the drug development process from early research through commercialization.
Clinical sas course syllabus
The document outlines the syllabus for a Clinical SAS course focusing on drug discovery and development processes. The syllabus covers an introduction to clinical trials including their phases and regulations, preparing and analyzing clinical trial data using SAS, generating tables, listings and graphs from clinical data, and performing statistical analyses. Students will learn how to clean, categorize and summarize clinical data, create analysis datasets, report adverse events, and obtain descriptive and inferential statistics to analyze efficacy, safety and time-to-event data. The course aims to provide skills relevant for clinical data management roles in the pharmaceutical industry.
resumeHirokoOtao_20161023
Hiroko Otao has over 10 years of experience in project management and clinical research. She has managed over 40 clinical studies for conditions such as psoriasis, asthma, and COPD while working at CMIC CRO and GlaxoSmithKline. Her experience includes vendor management, budgeting, reporting, customs clearance, and translating documents between English and Japanese. She is proficient in English, Mac and PC programs, and has a B.A. in Agricultural Science from Tokyo University of Agriculture.
Market Access Climate Change Webinar_the Evolving Impact of Product Listing A...
The document discusses recent developments regarding product listing agreements (PLAs) with the pan-Canadian Pharmaceutical Alliance (pCPA) and private payers in Canada. It notes that the pCPA office is now operational, which could standardize and improve the negotiation process. It also discusses Quebec recently joining pCPA negotiations, which may lead to more products being listed faster in that province. The document also examines the growing interest of private payers in Canada in negotiating their own PLAs, especially for specialty products, and finds that these agreements will likely become more important and prevalent over time.
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy post-approval solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Presentation for UMass Workshop
How True Open Innovation TM and its global network can expand the opportunity for drug development by increasing efficiency and decreasing costs
Luca Rastelli, PhD
Boston Strategics Corporation
October, 2013
What's hot (20)
Webinar slides: ISO IDMP via Regulatory Master Data Management
Webinar slides: ISO IDMP via Regulatory Master Data Management
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Cultural Relationship between Quality of Drugs and Prevailing Regulatory Envi...
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
Pharmaceutical Scientific and Regulatory Practices (12 April 2017)
How does the licensing process differ for in-licensing and out-licensing comp...
How does the licensing process differ for in-licensing and out-licensing comp...
Medelis Overview - A Specialized Oncology CRO - Q315
Medelis Overview - A Specialized Oncology CRO - Q315
Market Access Climate Change Webinar_the Evolving Impact of Product Listing A...
Market Access Climate Change Webinar_the Evolving Impact of Product Listing A...
Similar to Company Presentation Final June 2008
Regulatory Affairs 2010
Speid and Associates is a Regulatory Affairs and Drug Development Consultancy Company. (Slides produced in 2010)
INC Research Consulting v1
INC Research is a global consulting firm that provides advisory and implementation support services to the biopharmaceutical industry. They help clients with development, regulatory, quality and compliance, pharmacovigilance, and market development. Their team of over 50 consultants uses therapeutic expertise and consulting frameworks to deliver strategic solutions and help clients achieve their business goals.
Aagami Inc. Company Presentation
A life sciences consulting firm based in Chicago, Aagami Inc., offers strategic consulting, technology licensing, and business/market research services to support global biotech, pharmaceutical, medical device, and consumer health companies in their initiatives with India and Asia. The document provides details on Aagami's services, approach, clients, leadership team, and case studies highlighting strategic partnerships and licensing deals facilitated by Aagami that helped clients establish partnerships and reduce costs in emerging markets.
Updated capabilities overview1
Orbis Clinical is a consulting firm focused on providing regulatory affairs, quality assurance, drug safety, and risk management expertise to biopharmaceutical clients. It has over 70 employees and has experienced strong revenue growth. Orbis Clinical delivers flexible, client-driven solutions through engaged consultants and a large virtual bench of additional experts.
Nine Tz Overview
Nine-TZ is a healthcare business consultancy that partners with clients in North America, Europe, and Australia to help achieve their commercial objectives through business development advice, implementation, and support. They specialize in developing and executing market expansion initiatives, sourcing acquisitions, and augmenting resources. Nine-TZ leverages the expertise of its principals and advisors in areas like investment banking, marketing, and regulatory affairs to deliver a range of advisory services to pharmaceutical, biotech, and medical device companies.
Careers in pharma industry
This document provides an overview of various career opportunities in the pharmaceutical industry in India and abroad. It discusses roles in areas such as research and development, clinical research, contract research organizations, regulatory affairs, sales and marketing, product management, medical writing, advertising, consultancy, business development, manufacturing, quality control, quality assurance, medical reviewing, supply chain management, and government sectors. It also offers suggestions for pharmacy students to help them excel in their careers, such as developing self-confidence, networking, attending conferences, and lifelong learning. Contact information is provided for anyone seeking additional help or information.
Medtech.Capabilities.Frost & Sullivan.2009
Frost & Sullivan is a growth consulting company. The "Healthcare Practices" focuses on identifying emerging opportunities in Medical Devices industry and offer various market strategies.
InvenStar* CRC Capabilities
- InvenStar* CRC is a clinical research organization founded in 2008 by Dr. Shiva Murthy to support new drug development and clinical research according to ethical standards.
- The organization aims to provide quality clinical research services and has contracted over 5 projects with national and international clients in its first years of operation.
- InvenStar* CRC offers services including clinical trial support, medical education courses, and identifying software solution providers for applications like laboratory data management, hospital information systems, and eBlood banking. Revenue is also used for charitable activities through a trust.
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 most innovative pharma and biotech solution providers, 2020 september 2020; Insights Success has published The 10 most innovative pharma and biotech solution providers.
A Day in the Life of a Medical Director
The Medical Director oversees all activities of a company's Medical Department and contributes to senior leadership. Their day involves emails and phone calls about clinical trials, regulations, and health economics. They attend internal meetings on research, regulations, reimbursement, and business strategies. External meetings include advising investigators and regulators. As the senior medical advisor, they provide clinical guidance across the company.
Aptuit Consulting Inc
The document discusses Aptuit, a pharmaceutical services company that conducts drug development on a contract basis. It describes Aptuit's mission to improve the drug development process for both large and small companies. It also introduces Aptuit's INDiGO program which provides expert drug development teams to accelerate programs from the API stage through Phase 2a clinical trials. Outsourcing development to Aptuit can save emerging biopharma companies significant costs compared to developing drugs in-house.
Introducing StratAdviser Ltd
£1,000.00
Manager: £1,500.00
Strategic Consultant
£1,500.00
Medical Consultant
£1,500.00
Legal Consultant
£1,500.00
Communication Consultant
£1,500.00
Project Manager
£1,000.00
Administrative Support
£500.00
08/02/2014 confidential
35
Our Costing Procedure
1. Initial meeting to understand the need
2. Proposal of the appropriate level of advice
3. Estimate of required time and team
4. Costing based on our grid
5.
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
June 23, 2010 webinar sponsored by The Weinberg Group, with an emphasis on key issues to explore during due diligence in acquiring FDA-regulated products or companies.
Regulatory Affairs
Regulatory affairs professionals ensure public health by controlling the safety and efficacy of products. They keep track of changing legislation and advise their company on legal and scientific requirements. They collect and evaluate scientific data, present registration documents to regulatory agencies, and obtain marketing authorization for products. A good regulatory affairs professional helps maximize resources and serves as the first point of contact between a company and government authorities.
BioClinitech- Services And Capabilities
We are a Medico-Marketing Support Service and Customized IT Solutions Company established
in 2004 and offering innovative products and services to the global pharmaceutical and biotech
industries. Headquartered in Mumbai with a branch office in Hyderabad, the firm was conceived as an attempt to manage the information overload and provide customized and innovative solutions to the global healthcare and allied industries.
The team is a blend of global professionals with wide experience in Healthcare, IT, Biotechnology
and broad training in business and strategy
Our products and services provide clients with the innovative solutions to maximize growth
opportunities and life-cycle of existing products.
Business model includes a comprehensive suite of services designed to impart a global
perspective in two distinct portfolios: IT Solutions - Website Development & Maintenance and
Medico-Marketing Support Services
Hoffman la roche business review.pptx
This document provides an overview and comparison of pharmaceutical companies Hoffman La Roche, Janssen, and Novartis. It begins with an introduction to Roche, including its founding, size, ownership, and subsidiaries. It then discusses Roche's board of directors and corporate governance practices. The document outlines Roche's business model, focusing on elements like personalization, partnerships, and revenue sources. It also summarizes Janssen's profile as a Johnson & Johnson subsidiary and highlights elements of its business model and demand planning practices. Key financial and SWOT analyses are presented for Roche.
SRINIVASAN_AResume(2016) for Linked In
Aloka Srinivasan is seeking a leadership position in regulatory affairs. She has over 15 years of experience at the FDA and in the pharmaceutical industry evaluating drug applications and submissions. She has extensive experience reviewing various application types, including ANDAs, NDAs, INDs, and DMFs, across many therapeutic areas. She also has experience establishing new divisions and programs at the FDA and writing numerous guidance documents.
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
This document provides an analysis for a corporate venture capital fund to identify potential investment targets in the point-of-care diagnostics segment. It outlines the client's problem of seeking new revenue sources and growth options. The document analyzes segments using the VESSEL framework, identifies point-of-care diagnostics as the most promising, and provides a SWOT analysis. Four companies are then shortlisted in this segment based on an assessment framework. The most attractive target, a pharmaceutical IT company, is identified based on organizational compatibility, synergy, and financial considerations.
Critical Success Factors for a Medical Device Company
Critical success factors for a medical device company include developing a strong business plan, securing adequate funding, building a capable team, navigating the FDA approval process, and establishing reimbursement. The business plan should explain the vision and strategy, understand the market and competition, and include financial projections. Funding typically comes from personal investments initially and then venture capital. Assembling the right people with relevant expertise is also crucial. Navigating FDA approval and establishing reimbursement are major hurdles that require understanding regulations which are complex and changing.
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
This document provides an overview of consulting services offered by Sai Pharma Solutions Inc. related to quality management, regulatory affairs, and GMP compliance for pharmaceutical industries. The company's vision is to help clients achieve global regulatory compliance through education, training, auditing, and documentation services. Key services include GAP analyses, audits and checklists, SOP development, regulatory submissions, technical support, and online consultations. The goal is to help clients obtain regulatory approval by ensuring their facilities, equipment, methods, and personnel meet all necessary qualifications and standards.
Similar to Company Presentation Final June 2008 (20)
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
Critical Success Factors for a Medical Device Company
Critical Success Factors for a Medical Device Company
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Recently uploaded
Creative Web Design Company in Singapore
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Know what your zodiac sign says about your taste in food! Explore how the 12 zodiac signs influence your culinary preferences with insights from MyPandit. Dive into astrology and flavors!
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Explore the fascinating world of the Gemini Zodiac Sign. Discover the unique personality traits, key dates, and horoscope insights of Gemini individuals. Learn how their sociable, communicative nature and boundless curiosity make them the dynamic explorers of the zodiac. Dive into the duality of the Gemini sign and understand their intellectual and adventurous spirit.
2022 Vintage Roman Numerals Men Rings
Discover timeless style with the 2022 Vintage Roman Numerals Men's Ring. Crafted from premium stainless steel, this 6mm wide ring embodies elegance and durability. Perfect as a gift, it seamlessly blends classic Roman numeral detailing with modern sophistication, making it an ideal accessory for any occasion.
https://rb.gy/usj1a2
Best practices for project execution and delivery
A select set of project management best practices to keep your project on-track, on-cost and aligned to scope. Many firms have don't have the necessary skills, diligence, methods and oversight of their projects; this leads to slippage, higher costs and longer timeframes. Often firms have a history of projects that simply failed to move the needle. These best practices will help your firm avoid these pitfalls but they require fortitude to apply.
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
On episode 272 of the Digital and Social Media Sports Podcast, Neil chatted with Brian Fitzsimmons, Director of Licensing and Business Development for Barstool Sports.
What follows is a collection of snippets from the podcast. To hear the full interview and more, check out the podcast on all podcast platforms and at www.dsmsports.net
Easily Verify Compliance and Security with Binance KYC
Use our simple KYC verification guide to make sure your Binance account is safe and compliant. Discover the fundamentals, appreciate the significance of KYC, and trade on one of the biggest cryptocurrency exchanges with confidence.
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
“After being the most listed dog breed in the United States for 31
years in a row, the Labrador Retriever has dropped to second place
in the American Kennel Club's annual survey of the country's most
popular canines. The French Bulldog is the new top dog in the
United States as of 2022. The stylish puppy has ascended the
rankings in rapid time despite having health concerns and limited
color choices.”
DearbornMusic-KatherineJasperFullSailUni
My powerpoint presentation for my Music Retail and Distribution class at Full Sail University
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
Business storytelling: key ingredients to a story
Storytelling is an incredibly valuable tool to share data and information. To get the most impact from stories there are a number of key ingredients. These are based on science and human nature. Using these elements in a story you can deliver information impactfully, ensure action and drive change.
Understanding User Needs and Satisfying Them
https://www.productmanagementtoday.com/frs/26903918/understanding-user-needs-and-satisfying-them
We know we want to create products which our customers find to be valuable. Whether we label it as customer-centric or product-led depends on how long we've been doing product management. There are three challenges we face when doing this. The obvious challenge is figuring out what our users need; the non-obvious challenges are in creating a shared understanding of those needs and in sensing if what we're doing is meeting those needs.
In this webinar, we won't focus on the research methods for discovering user-needs. We will focus on synthesis of the needs we discover, communication and alignment tools, and how we operationalize addressing those needs.
Industry expert Scott Sehlhorst will:
• Introduce a taxonomy for user goals with real world examples
• Present the Onion Diagram, a tool for contextualizing task-level goals
• Illustrate how customer journey maps capture activity-level and task-level goals
• Demonstrate the best approach to selection and prioritization of user-goals to address
• Highlight the crucial benchmarks, observable changes, in ensuring fulfillment of customer needs
How to Implement a Real Estate CRM Software
To implement a CRM for real estate, set clear goals, choose a CRM with key real estate features, and customize it to your needs. Migrate your data, train your team, and use automation to save time. Monitor performance, ensure data security, and use the CRM to enhance marketing. Regularly check its effectiveness to improve your business.
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...
Dive into the steadfast world of the Taurus Zodiac Sign. Discover the grounded, stable, and logical nature of Taurus individuals, and explore their key personality traits, important dates, and horoscope insights. Learn how the determination and patience of the Taurus sign make them the rock-steady achievers and anchors of the zodiac.
How MJ Global Leads the Packaging Industry.pdf
MJ Global's success in staying ahead of the curve in the packaging industry is a testament to its dedication to innovation, sustainability, and customer-centricity. By embracing technological advancements, leading in eco-friendly solutions, collaborating with industry leaders, and adapting to evolving consumer preferences, MJ Global continues to set new standards in the packaging sector.
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
In the recent edition, The 10 Most Influential Leaders Guiding Corporate Evolution, 2024, The Silicon Leaders magazine gladly features Dejan Štancer, President of the Global Chamber of Business Leaders (GCBL), along with other leaders.
Digital Marketing with a Focus on Sustainability
Digital Marketing best practices including influencer marketing, content creators, and omnichannel marketing for Sustainable Brands at the Sustainable Cosmetics Summit 2024 in New York
Recently uploaded (20)
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Brian Fitzsimmons on the Business Strategy and Content Flywheel of Barstool S...
Easily Verify Compliance and Security with Binance KYC
Easily Verify Compliance and Security with Binance KYC
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
How are Lilac French Bulldogs Beauty Charming the World and Capturing Hearts....
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdf
Company Presentation Final June 2008
- 1. Speid & Associates, Inc. Consultancy Services, Inc. Lorna Speid, Ph.D., RAC President Speeding New Drugs to Market ® www.drugstomarket.com
- 9. How We Work We believe that a successful development program requires more than serendipity or luck --- We have a proven track record of past achievements
- 10. How We Work It is very easy to throw money away if you do not have the right people on your team --- We are experienced in working with diverse teams -- We will ensure that the knowledge remains within the client company by working closely with the team
- 11. How We Work We work with our clients to achieve successful global registration, as expeditiously as possible --- we identify the pieces of the jigsaw and help the client to work out how they fit together
- 13. How We Work We can help you to determine what your next move should be in the drug/device/diagnostic or combination development program
- 14. How We Work – the Starting Point Review of Regulations US Europe International Review of Guidelines US Europe International Review of ICH guidelines Development of global and US regulatory and development strategy
Editor's Notes
- 39